World-leading NHS genomics lab launches to improve care for cancer patients

A world-leading NHS genomics lab has launched in London to enhance care for cancer patients. This centre is the first of its kind to provide a new generation of cancer diagnostics called composite biomarker testing. The innovative approach combines specific data regarding the patient and their tumour with artificial intelligence (AI). By integrating these elements, the facility aims to build the fullest possible picture of a person's cancer to improve overall diagnostic accuracy and patient outcomes.